Similar articles

• Strengths and limitations of healthcare databases in the evaluation of hypoglycaemia.

  Loke YK, Mattishent K. Loke YK, et al. Diabetes Obes Metab. 2017 Oct;19(10):1337-1338. doi: 10.1111/dom.12984. Epub 2017 Jul 13. Diabetes Obes Metab. 2017. PMID: 28449416 No abstract available.
• Risk factors and outcome differences in hypoglycaemia-related hospital admissions: A case-control study in England.

  Zaccardi F, Webb DR, Davies MJ, Dhalwani NN, Housley G, Shaw D, Hatton JW, Khunti K. Zaccardi F, et al. Diabetes Obes Metab. 2017 Oct;19(10):1371-1378. doi: 10.1111/dom.12941. Epub 2017 Apr 21. Diabetes Obes Metab. 2017. PMID: 28295974
• The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study.

  Derijks HJ, Heerdink ER, De Koning FH, Janknegt R, Klungel OH, Egberts AC. Derijks HJ, et al. Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):336-44. doi: 10.1002/pds.1562. Pharmacoepidemiol Drug Saf. 2008. PMID: 18302302
• Increasing awareness of hypoglycaemia in patients with type 2 diabetes treated with oral agents.

  Barnett AH, Brice R, Hanif W, James J, Langerman H. Barnett AH, et al. Curr Med Res Opin. 2013 Nov;29(11):1503-13. doi: 10.1185/03007995.2013.834250. Epub 2013 Sep 6. Curr Med Res Opin. 2013. PMID: 23952328 Review.
• Severe hypoglycaemia in type 1 diabetes: impact of the renin-angiotensin system and other risk factors.

  Pedersen-Bjergaard U. Pedersen-Bjergaard U. Dan Med Bull. 2009 Nov;56(4):193-207. Dan Med Bull. 2009. PMID: 19939337 Review.